S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Sell every Stock except ONE (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Buy THIS stock before Taiwan is attacked (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Buy THIS stock before Taiwan is attacked (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Sell every Stock except ONE (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Buy THIS stock before Taiwan is attacked (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Buy THIS stock before Taiwan is attacked (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Sell every Stock except ONE (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Buy THIS stock before Taiwan is attacked (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Buy THIS stock before Taiwan is attacked (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Sell every Stock except ONE (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Buy THIS stock before Taiwan is attacked (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Buy THIS stock before Taiwan is attacked (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
NASDAQ:CPIX

Cumberland Pharmaceuticals (CPIX) Stock Forecast, Price & News

$1.58
-0.02 (-0.94%)
(As of 05/26/2023 04:00 PM ET)
Compare
Today's Range
$1.58
$1.63
50-Day Range
$1.59
$2.01
52-Week Range
$1.55
$2.91
Volume
16,700 shs
Average Volume
21,846 shs
Market Capitalization
$22.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CPIX stock logo

About Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.

Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPIX Stock News Headlines

Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
See More Headlines
Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPIX Company Calendar

Last Earnings
3/07/2023
Today
5/29/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NASDAQ:CPIX
CUSIP
23077010
Employees
83
Year Founded
1999

Profitability

Net Income
$-5,570,000.00
Pretax Margin
-10.00%

Debt

Sales & Book Value

Annual Sales
$42.01 million
Cash Flow
$0.47 per share
Book Value
$2.45 per share

Miscellaneous

Free Float
8,370,000
Market Cap
$22.90 million
Optionable
Optionable
Beta
0.34

Social Links


Key Executives

  • A. J. KazimiA. J. Kazimi
    Chairman & Chief Executive Officer
  • John M. Hamm
    Chief Financial & Accounting Officer
  • James L. Herman
    Chief Compliance Officer & Senior Vice President
  • Todd Anthony
    Executive Director-Organizational Development
  • Adam S. Mostafa
    Managing Director













CPIX Stock - Frequently Asked Questions

How have CPIX shares performed in 2023?

Cumberland Pharmaceuticals' stock was trading at $2.25 on January 1st, 2023. Since then, CPIX stock has decreased by 29.6% and is now trading at $1.5850.
View the best growth stocks for 2023 here
.

When is Cumberland Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our CPIX earnings forecast
.

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) posted its quarterly earnings data on Tuesday, March, 7th. The specialty pharmaceutical company reported ($0.06) EPS for the quarter. The specialty pharmaceutical company earned $9.12 million during the quarter. Cumberland Pharmaceuticals had a negative net margin of 9.97% and a positive trailing twelve-month return on equity of 4.76%.

What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?

9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cumberland Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS).

What is Cumberland Pharmaceuticals' stock symbol?

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

Who are Cumberland Pharmaceuticals' major shareholders?

Cumberland Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (4.23%), Renaissance Technologies LLC (3.97%) and BlackRock Inc. (0.92%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas.
View institutional ownership trends
.

How do I buy shares of Cumberland Pharmaceuticals?

Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cumberland Pharmaceuticals' stock price today?

One share of CPIX stock can currently be purchased for approximately $1.59.

How much money does Cumberland Pharmaceuticals make?

Cumberland Pharmaceuticals (NASDAQ:CPIX) has a market capitalization of $22.90 million and generates $42.01 million in revenue each year. The specialty pharmaceutical company earns $-5,570,000.00 in net income (profit) each year or ($0.28) on an earnings per share basis.

How can I contact Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The official website for the company is www.cumberlandpharma.com. The specialty pharmaceutical company can be reached via phone at (615) 255-0068, via email at investors@cumberlandpharma.com, or via fax at 615-255-0094.

This page (NASDAQ:CPIX) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -